Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape

Immunological Reviews

Volumn 168, Issue , 1999, Pages 271-286

  Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; EPITOPE; FAS ANTIGEN; GLYCOPROTEIN GP 39; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS ENVELOPE PROTEIN;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENETIC RECOMBINATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; LEUKEMIA; LYMPHOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RETROVIRUS; REVIEW;

ANIMALS; ENDOGENOUS RETROVIRUSES; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; MICE, INBRED AKR; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033026567     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01298.x     Document Type: Review

References (93)

1. 1. Gross L. "Spontaneous" leukemia developing in C3H mice following inoculation in infancy with AK leukemic extracts, or AK embryos. Proc Soc Exp Biol Med 1951;76:27-32.
2. 2. Cloyd MW, Thompson MM, Hartley JW. Host range of mink cell focus-inducing viruses. Virology 1985;140:239-248.
3. 3. Fischinger PJ, Nomura S, Bolognesi DP. A novel murine oncornavirus with dual eco and xenotropic properties. Proc Natl Acad Sci 1975;72:5150-5155.
4. 4. Kondo T, et al. A single retroviral gag precursor signal peptide recognized by FBL-3 tumor-specific cytotoxic T lymphocytes. J Virol 1995;69:6735-6741.
5. 5. Chen W, Qin H, Chesebro B, Cheever MA. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney and Rauscher murine leukemia virus-induced tumors. J Virol 1996;70:7773-7782.
6. 6. Chesebro B, Miyazawa M, Britt WJ. Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu Rev Immunol 1990;8:477-499.
7. 7. Fan H. Retroviruses and their role in cancer. In: Levy JA, ed. The retroviridae. Vol 3. New York: Plenum Press; 1994.
8. 8. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601-624.
9. 9. Deverson E, Gow IR, Coadwell WJ, Monaco JJ, Butcher JC, Howard JC. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 1990;348:738-741.
10. 10. Spies T, et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 1990;348:744-747.
11. 11. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990;250:1723-1726.
12. 12. Schmid DS, Rouse BT. The role of T cell immunity in control of herpes simplex virus. Curr Top Micr Immunol 1992;179:57-74.
13. 13. Lilly F. The histocompatibility-2 locus and susceptibility to tumor induction. Natl Cancer Inst Monogr 1966;22:631-636.
14. 14. Lilly F. The role of genetics in Gross virus leukemogenesis. Compar Leuk Res 1969;36:213-230.
15. 15. Green WR. Genetic control of the induction of cytolytic T lymphocyte resoponses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control. J Immunol 1984;132:2658-2664.
16. 16. Green WR, Nowinski RC, Henney CS. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J Exp Med 1979;150:51-66.
17. 17. Green WR. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the Gross cell surface antigen. J Immunol 1980;125:2584-2590.
18. 18. Green WR, Nowinski RC, Henney CS. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. J Immunol 1980;125:647-655.
19. 19. Lowy DR, Rands E, Chattopadhyay SK, Garon CF, Hager GL. Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc Natl Acad Sci USA 1980;77:614-618.
20. 20. White HD, Robbins MD, Green WR. Mechanism of escape of endogenous murine leukemia virus EMV-14 from recognition by anti-AKR/Gross MuLV cytotoxic T lymphocytes. J Virol 1990;64:2608-2619.
21. 21. Plata F, Lilly F. Viral specificity of H-2 restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia viruses. J Exp Med 1979;150:1174-1186.
22. 22. Plata F, Kalil J, Zilber M T, Fellous M, Levy D. Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor. J Immunol 1983;131:2551-2556.
23. 23. Plata F, Langlade-Demoyen P, Abastado J-P, Berbar T, Kourilsky P. Molecular definition of retrovirus-induced antigens recognized by tumour-specific H-2-restricted cytolytic T lymphocytes. J Immunogenet 1986;13:263-268.
24. 24. Plata F, Langlade-Demoyen P, Abastado J-P, Berbar T, Kourilsky P. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell 1987;48:232-240.
25. 25. Ramanathapuram M, Graziano RF, Green WR. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. J Immunol 1986;136:2271-2279.
26. 26. Morse HC III, Chatlopadhyay SK, Makino M, Fredrickson TN, Ambros HW, Hartley JW. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 1992;6:607-621.
27. 27. Jolicoeur JP. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study AIDS pathogenesis. FASEB J 1991;5:2398-2405.
28. 28. Sijts AJAM, Ossendorp F, Mengede EAM, van den Elsen PJ, Melief CJM. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J Immunol 1994;152:106-116.
29. h-restricted peptide from the p1 5E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR 623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J Virol 1994;68:897-904.
30. 30. Falk K, Rotzshcke O, Stevanovic S, Jung G, Rammensee H-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-296.
31. 31. Herr W. Nucleotide sequence of AKV murine leukemia virus. J Virol 1984;49:471-478.
32. b mice. Virology 1994;202:500-505.
33. 33. Green WR. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone. Eur J Immunol 1983;13:863-870.
34. 34. Green WR, Brown MA. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor. Eur J Immunol 1983;13:871-877.
35. 35. White HD, Green WR, Gine NR. Molecular cloning of infectious ecotropic murine leukemia virus AK7 from an emv-14-positive AKXL-5 mouse and the resistance of AK7 to recognition by cytotoxic T lymphocytes. J Virol 1993;67:5045-5050.
36. h-restricted epitopes encoded by the endogenous ecotropic murine leukemia virus AKR623 that are recognized by anti-AKR/Gross MuLV CTL. Viral Immunol 1994;7:51-59.
37. b mice. Cell Immunol 1988;116:123-134.
38. b haplotype. J Immunol 1984;132:2665-2671.
39. b congenic mice: age-dependent conversion to a nonresponder phenotype. J Immunol 1987;138:1602-1606.
40. b mouse strains. Cell Immunol 1988;113:308-319.
41. 41. Coppola MA, Lam TM, Strawbridge RR, Green WR. Recognition of endogenous ecotropic murine leukaemia viruses by anti-AKR/Gross virus cytotoxic T lymphocytes (CTL):epitope variation in a CTL-resistant virus. J Gen Virol 1995;76:635-641.
42. 42. Green WR, Graziano RF. Cytolytic F lymphocyte defined retroviral antigens on normal cells: encoding by the Akv-1 proviral locus. Immunogenetics 1986;23:106-110.
43. 43. Steffen DL, Raylor BA, Weinberg RA. Continuing germ line integration of Akv proviruses during the breeding of AKR mice and derivative recombinant inbred strains. J Virol 1982;42:165-175.
44. 44. Kim V, Green WR. The role of proximal and distal sequence variations in the presentation of an immunodominant CTL epitope encoded by the ecotropic AK7 MuLV. Virology 1997;236:221-233.
45. 45. Chattopadhyay SK, Morse HC III, Makino M, Ruscetti SK, Hartley JW. Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus induced immunodeficiency syndrome of mice. J Virol 1991;65:4232-4241.
46. 46. Khan AS. Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus forming murine leukemia viruses. J Virol 1984;50:864-871.
47. 47. Ossendorp F, et al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 1996;5:115-124.
48. 48. Kim V, Green WR. A single amino acid variation within an immunodominant AKR/Gross MuLV CTL epitope leads to a loss in immunogenicity. Viral Immunol 1998;11:197-213.
49. 49. Evavold BD, Sloan-Lancaster J, Allen PM. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 1993;14:602-609.
50. h molecule. Nature 1990;348:213-216.
51. 51. Neisig A, et al. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class 1-presentable peptides and the effect of flanking sequences. J Immnnol 1995;154:1273-1279.
52. b. Science 1992;257:919-927.
53. 53. Matsumura M, Fremont DH, Peterson PA, Wilson IA. Emerging principles of the recognition of peptide antigens by MHC class I molecules. Science 1992;257:927-934.
54. 54. Rammensee H-G, Falk K, Rotschke O. Peptides naturally presented by MHC class I molecules. Annn Rev Immunol 1993;11:213-244.
55. + cytotoxic T cells. J Virol 1993;67:4086-4092.
56. 56. Laterjet R, Duplan J-F. Experiment and discussion on leukacmogenesis by cell-free extracts of radiation induced leukaemia in mice. Int J Radiat Biol 1962;5:339-344.
57. 57. Mosier DE, Yetter RA, Morse HC III. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med 1985;161:766-784.
58. 58. Pattengale PK, et al. Immunopathology of B cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV). Am J Pathol 1982;107:362-377.
59. 59. Jenkins NA, Copeland NG, Taylor BA, Lee BK. Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA in chromosomes of Mus musculus. J Virol 1982;43:26-36.
60. k gene products in AKR leukemia. Immunogenetics 1982;16:257-264.
61. k gene product(s) from an AKR spontaneous leukemia. Immunogenetics 1979;8:311-318.
62. 62. Festenstein H, Schmidt W. Variation in MHC antigenic profiles of tumor cells and its biological effects. Immunol Rev 1981;60:85-127.
63. 63. Green WR, Phillips JD. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-γ. J Immunol 1986;137:814-818.
64. k augmentation in a leukemia virus induced tumor is due to a cisdominant effect. J Exp Med 1988;167:1616-1624.
65. 65. Rich RF, Gaffney KJ, White HD, Green WR, Differential up-regulation of H-2D versus H-2K class I major histocompatibility expression by interferon-γ: evidence against a trans-acting allele-specific factor. Interferon Res 1990;10:505-514.
66. 66. Schwarz DA, Buhlmann JE, Kuhne MR, Lam TM, White HD, Green WR. Novel regulation of an MHC class I gene response to interferon-γ. Cell Immunol 1993;150:90-100.
67. 67. Green WR, Rich RF. Genetic control of CTI. responses to AKR/Gross virus: effect of inheritance of Akv proviruses. Immunogenetics 1988;27:304-312.
68. h and C57BL/6 mouse strains. J Immunol 1992;149:1593-1598.
69. b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice. J Immunol 1991;146:2469-2477.
70. b mice. J Immunol 1992;148:2961-2967.
71. b congenic mice for anti-AKR/Gross Mul.V CTL responses: involvement of inhibitory cells as defined by adoptive transfer experiments. Cell Immunol 1995;160:139-151.
72. b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation. J Virol 1996;70:402-414.
73. 73. Fink PJ, Shimonkevitz RP, Bevan MJ. Veto cells. Annu Rev Immunol 1988;6:115-137.
74. b splenic veto cells. J Virol (In press).
75. 75. Coppola MA, Green WR, Rich RF. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV. Viral Immunol 1996;9:107-119.
76. 76. Hartley JW, Fredrickson TN, Yetter RA, Makino M, Morse HC. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol 1989;63:1223-1231.
77. 77. Makino M, Morse HC III, Fredrickson TN, Hartley JW. H-2-associated and background genes influence the development of a murine retrovirus-induced immunodeficiency syndrome. J Immunol 1990;144:4347-4355.
78. + T cells in resistance to murine AIDS in A/J mice. J Immunol 1992;149:1702-1706.
79. 79. Erbe JG, Green KA, Crassi KM, Morse HC III, Green WR. Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome (MAIDS). J Virol 1992;66:3251-3256.
80. 80. Green WR, Crassi KM, Schwarz DA, Green KA. Cytotoxic T lymphocytes directed against MAIDS-associated tumors and cells from mice infected by the LP-BM5 MAIDS defective retrovirus. Virology 1994;200:292-296.
81. 81. Green WR, Green KA, Crassi KM. Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency. J Virol 1994;68:4679-4684.
82. 82. Schwarz DA, Green WR. CTL responses to the gag polyprotein encoded by the murine AIDS defective retrovirus are strain dependent. J Immunol 1994;153:436-441.
83. 83. Mayrand S-M, Schwarz DA, Green WR. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. J Immunol 1998;160:39-50.
84. 84. Mayrand SM, Green WR. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol Today 1998;19:551-556.
85. 85. Wang R, Parkhurst M, Kawakami Y, Robbins P, Rosenberg SA. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med 1996;183:1131-1140.
86. 86. Mosier DE, Yeuer RA, Morse HC III. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J Exp Med 1987;165:1737-1742.
87. + T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med 1988;168:623-635.
88. 88. Huang M, Simard C, Kay DG, Jolicoeur P. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J Virol 1991;65:6562-6571.
89. 89. Kim WK, Tang Y, Kenny JJ, Longo DL, Morse HC III. In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. J Virol 1994;68:6767-6769.
90. 90. Cerny A, et al. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J Exp Med 1990;171:315-320.
91. + T cells. J Virol 1994;68:5819-5824.
92. 92. Green KA, et al. Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J Virol 1996;70:2569-2575.
93. 93. Green KA, Noelle RJ, Green WR. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS. Virology 1998;241:260-268.